NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/13/2025
Back to search
Official data from USPTO
ACCELERATING MEDICINES PARTNERSHIP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACCELERATING MEDICINES PARTNERSHIP
ST13
US500000086141533Class
35, 36, 42, 44
Filing
86141533
Registration
4782721
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
12/02/2025
Trademark type
Word
Nice classes
35, 36, 42, 44
Filing date
12/12/2013
Registration date
07/28/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/13/2025
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2014-02-00
First use in commerce
2014-02-00
Drawing code
4
Owner type
99
Owner location
Bethesda, MD
Examiner
WILLIS,PAMELA Y
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
U.S. Department of Health and Human Services
Representatives
Angela Y. Dai HHS OFFICE OF THE GENERAL COUNSEL
Technical classification
Nice Classes
Class 35Class 36Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management and business development servicesmanagement of research grantsbusiness program managementpromoting collaboration within the scientificresearch and provider communities to achieve advances in the fields of biomedical research and pharmaceutical research and developmentbusiness management of programs related to public private-partnerships in the fields of biomedical research and pharmaceutical research and development; Promotion of the research programs of others; Promoting public awareness of public-private partnerships in the fields of biomedical research and pharmaceutical research and development; promoting the interests of public-private partnerships in the fields of biomedical research and pharmaceutical research and development; Arranging and conducting business conferences for research scientists and health care professionals
Class 36
Providing grants for biomedical research and pharmaceutical research and development
Class 42
Providing medical and scientific research information in the field of biomedical products and pharmaceuticals via a website
Class 44
Providing information relating to diagnosticprophylactictherapeutic properties of pharmaceuticals and biomedical products
Publications
History of USPTO decisions and trademark events.
44 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/13/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/12/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
07/25/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/28/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/03/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/03/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/03/2021
E815
TEAS SECTION 8 & 15 RECEIVED
07/28/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/28/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/28/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/24/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/23/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/16/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/15/2015
EX1G
SOU EXTENSION 1 GRANTED
06/15/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/13/2015
IUAF
USE AMENDMENT FILED
05/15/2015
EXT1
SOU EXTENSION 1 FILED
05/15/2015
EEXT
SOU TEAS EXTENSION RECEIVED
05/15/2015
EISU
TEAS STATEMENT OF USE RECEIVED
05/15/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/10/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/16/2014
PUBO
PUBLISHED FOR OPPOSITION
12/16/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/26/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/08/2014
ALIE
ASSIGNED TO LIE
11/05/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/21/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/17/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/01/2014
GNRT
NON-FINAL ACTION E-MAILED
10/01/2014
CNRT
NON-FINAL ACTION WRITTEN
10/01/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/25/2014
GNRT
NON-FINAL ACTION E-MAILED
03/25/2014
CNRT
NON-FINAL ACTION WRITTEN
03/25/2014
DOCK
ASSIGNED TO EXAMINER
03/21/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/26/2013
NWAP
NEW APPLICATION ENTERED
12/16/2013
Continuous trademark protection
Get notified about every new filing that threatens ACCELERATING MEDICINES PARTNERSHIP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.